Clarivate Plc Clarivate (NYSE: CLVT) Release its Annual Drugs to Watch Report Clarivate Plc (NYSE: CLVT) has publicly shared its annual Drugs to Watch report. The report has pinpointed drugs entering the market or introducing key indications in 2022 which are expected
